Apothecary Pharma recalls 22 vials of compounded tirzepatide over sterility
The FDA had warned the Cary, North Carolina pharmacy in December 2025 about sterile production problems. Check your vial's lot number and beyond-use date.
Recap by typeshit. Full story at Democrat and Chronicle.